Skip to main content

Table 2 Pooled vaccine efficacy/effectiveness (VE) of PPV-23 against IPD and pneumococcal pneumonia (data from [83]).

From: Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond

  clinical trials VE [%] (95%CI) cohort studies case-control studies
IPD 73% (10-92) 45% (15-65) 59% (35-74)
pneumococcal pneumonia 64% (32-80) 48% (25-63) n.d.
  1. n.d. not done